Cambiar Investors LLC Sells 732 Shares of Colgate-Palmolive (NYSE:CL)

Cambiar Investors LLC trimmed its stake in Colgate-Palmolive (NYSE:CL) by 7.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,168 shares of the company’s stock after selling 732 shares during the period. Cambiar Investors LLC’s holdings in Colgate-Palmolive were worth $833,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. FMR LLC lifted its stake in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares during the period. Barclays PLC raised its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. State Street Corp lifted its position in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Nordea Investment Management AB boosted its stake in shares of Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its holdings in Colgate-Palmolive by 864.1% during the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after buying an additional 697,168 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent research reports. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $87.35 on Wednesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The firm has a market cap of $71.37 billion, a PE ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The firm has a fifty day moving average of $90.14 and a 200 day moving average of $96.69.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.